1Drop Diagnostics

Neuchatel, Switzerland Founded: 2012 • Age: 14 yrs
Finger-prick point-of-care diagnostics are provided for biomarker testing.
Request Access

About 1Drop Diagnostics

1Drop Diagnostics is a company based in Neuchatel (Switzerland) founded in 2012.. 1Drop Diagnostics has raised $7.75 million across 6 funding rounds from investors including Christian Wildmoser, Hans-Peter Strebel and Beat Schillig. 1Drop Diagnostics offers products and services including Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader. 1Drop Diagnostics operates in a competitive market with competitors including SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others.

  • Headquarter Neuchatel, Switzerland
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name 1Drop Sa
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.75 M (USD)

    in 6 rounds

  • Latest Funding Round
    $4.25 M (USD), Series A

    Oct 31, 2018

  • Investors
    Venturelab

    & 8 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of 1Drop Diagnostics

1Drop Diagnostics offers a comprehensive portfolio of products and services, including Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Assesses risk of heart disease via high-sensitivity CRP biomarker.

Evaluates cardiovascular risk beyond traditional cholesterol measures.

Checks blood sugar control and diabetes development risk.

Detects underdiagnosed kidney disease through function analysis.

Analyzes blood samples for multiple biomarkers in minutes.

People of 1Drop Diagnostics
Headcount 10-50
Employee Profiles 2
Board Members and Advisors 8
Employee Profiles
People
Joerg Ziegler
Co Founder, CTO
People
Jörg Ziegler
Co-Founder & CTO

Unlock access to complete

Board Members and Advisors
people
Nico De Rooij
Scientific Advisor
people
Markus Ehrat
Scientific Advisor
people
Hans Peter Herzig
Scientific Advisor
people
Per Magnus Kristiansen
Scientific Advisor

Unlock access to complete

Teams

Funding Insights of 1Drop Diagnostics

1Drop Diagnostics has successfully raised a total of $7.75M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $4.25 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series A — $4.2M
  • First Round
  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2018 Amount Series A - 1Drop Diagnostics Valuation Christian Wildmoser
Apr, 2016 Amount Series A - 1Drop Diagnostics Valuation

investors

Feb, 2016 Amount Seed - 1Drop Diagnostics Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in 1Drop Diagnostics

1Drop Diagnostics has secured backing from 9 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Christian Wildmoser, Hans-Peter Strebel and Beat Schillig. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Startup acceleration programs are operated across sectors to support growth.
Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Founded Year Domain Location
Blackbox is focused on elevating entrepreneurs through global connections.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by 1Drop Diagnostics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - 1Drop Diagnostics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

1Drop Diagnostics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 1Drop Diagnostics

1Drop Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SD Biosensor, GEN inCode, SpectraWAVE, Realview Imaging and Lepu Medical Technology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
domain founded_year HQ Location
Genetic and clinical data are integrated for precision cardiac medicines.
domain founded_year HQ Location
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
domain founded_year HQ Location
3D holographic display solutions for medical imaging are provided.
domain founded_year HQ Location
Interventional cardiology devices are developed and marketed globally.
domain founded_year HQ Location
Molecular diagnostic tests for cardiovascular disorders are developed and marketed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on 1Drop Diagnostics

Frequently Asked Questions about 1Drop Diagnostics

When was 1Drop Diagnostics founded?

1Drop Diagnostics was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Where is 1Drop Diagnostics located?

1Drop Diagnostics is headquartered in Neuchatel, Switzerland.

Is 1Drop Diagnostics a funded company?

1Drop Diagnostics is a funded company, having raised a total of $7.75M across 6 funding rounds to date.

What does 1Drop Diagnostics do?

1Drop Diagnostics was founded in 2012 in Neuchatel, Switzerland, within the health technology sector. Point-of-care diagnostic solutions are offered through finger-prick blood sampling. Lab-on-chip microfluidic technology is utilized to process small blood volumes, while advanced photonics detects fluorescence from immunoassays. Initial focus is placed on cardiovascular health, with biomarkers including NT-proBNP, D-Dimer, Troponin, and C-reactive protein. Operations emphasize accessible testing in clinical settings.

Who are the top competitors of 1Drop Diagnostics?

1Drop Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.

What products or services does 1Drop Diagnostics offer?

1Drop Diagnostics offers Inflammation Test, Cholesterol Test, Diabetes Risk Test, Kidney Function Test, and 1DROP Reader.

Who are 1Drop Diagnostics's investors?

1Drop Diagnostics has 9 investors. Key investors include Christian Wildmoser, Hans-Peter Strebel, Beat Schillig, Jean-Philippe De Toledo, and Venturelab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available